In a recent blog, I discussed the change in nomenclature for the conditions formerly known as Neurofibromatosis type 2 (NF2) and schwannomatosis. This change was based on the results of an ...
IVDR: where are we now in molecular testing? How IVDR implementation is progressing in molecular biology laboratories in different European countries IVDR, the new EU legislation for in-vitro ...
Please provide your email address to receive an email when new articles are posted on . Over the past 2 decades, a large body of research has shed light on the molecular determinants of many human ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback